摘要
目的:观察国产雷贝拉唑对幽门螺杆菌根除和溃疡愈合的疗效。方法:75例消化性溃疡患者,随机分为观察组28例服用雷贝拉唑、克拉霉素及呋喃唑酮;对照1组24例用奥美拉唑替代雷贝拉唑,其余与观察组相同;对照2组23例用泮托拉唑替代雷贝拉唑,其余与观察组相同。用药结束后2 8d复查。结果:各组总有效率和幽门螺杆菌清除率比较无统计学差异(P>0．05)。结论:国产雷贝拉唑三联短程疗法治疗溃疡病疗效确切。
Objective： To compare the efficacy of domestic rabeprazole for H. pylori and peptic ulcer. Method： Seventy-five patients with peptic ulcer were divided in to three groups randomly. The 1st group treated with rabeprazole, clarithromycin and furazolidone. The 2nd group treated with omeprazole, clarithromycin and furazolidone. The3rd group treated with pantoprazole, clarithromycin and furazolidone. Four weeks after theapy, all patients were re-examinated. Result： The total effective rate and the H. pylori eradication rate among the three groups showed no statistical difference （ P 〉 0.05 ）. Conclusion： Domestic rabeprazole-based triple short-term therapy is an effective therapy for peptic ulcers.
出处
《中国药师》
CAS
2006年第8期748-750,共3页
China Pharmacist
